Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 16,599 | 16,483 | 14,514 | 14,455 | 12,415 |
| Gross Profit | 16,599 | 16,483 | 14,514 | 14,455 | 12,415 |
| Operating Expenses | 19,644 | 24,819 | 18,515 | 15,467 | 13,746 |
| Operating Income | -3,044 | -8,335 | -4,001 | -1,013 | -1,331 |
| Interest Expense | 1 | 1 | 1 | 1 | 1 |
| Other Income | 4 | 108 | 140 | 165 | 93 |
| Pre-tax Income | -3,041 | -8,228 | -3,862 | -849 | -1,239 |
| Net Income Continuous | -3,041 | -8,228 | -3,862 | -849 | -1,239 |
| Net Income | $-3,041 | $-8,228 | $-3,862 | $-849 | $-1,239 |
| EPS Basic Total Ops | -0.08 | -0.23 | -0.11 | -0.19 | -0.03 |
| EPS Basic Continuous Ops | -0.08 | -0.23 | -0.11 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.08 | -0.23 | -0.11 | -0.19 | -0.03 |
| EPS Diluted Continuous Ops | -0.08 | -0.23 | -0.11 | -0.02 | -0.03 |
| EBITDA(a) | $-2,511 | $-7,905 | $-3,579 | $-502 | $-845 |